Opioids Completed Phase 2 Trials for Naloxone (DB01183)
Also known as: Opiate / Opioid / Opiates / Substance with opioid receptor agonist mechanism of action (substance) / Product containing opium alkaloid (product) / Opium alkaloid (substance) / Opiate Alkaloids / Product containing opioid receptor agonist (product)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0037703 (Opioids) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03223896 | Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray | Treatment |